[O1] Oral 1 ART-1 | IFFS2025 / JSRM70

詳細検索

セッション詳細

Oral

[O1]Oral 1 ART-1

2025年4月27日(日) 9:00 〜 9:45

Hall D5

Chair(s): Aisaku Fukuda (Japan), Lan N. Vuong (Viet Nam)

9:00 〜 9:09

[O1-1]Peripheral blood mononuclear cell therapy demonstrates significantly improved outcomes for challenging IVF patient groups in global clinical data

^○Yevheniia Zhylkova^1,2,3, Oleksandr Feskov^{1 2}, Stanislav Zhilkov^{1 3}, Kamden Burke¹ (1.Department of Laboratories, Cell Therapy Holdings LLC, 2.Department of Laboratories, IVF center of prof. Feskov, 3.Product Development, AB Fertility Inc)

9:09 〜 9:18

[O1-2]Three decades of assisted reproductive technology driving global trends in fertility success

^○Jessie Sutherland¹, Alexandra Peters^{1 2}, Shaun Roman³, Elizabeth Bromfield^{4 5 6}, Brett Nixon^{5 6}, Eileen McLaughlin⁷, Kirsty Pringle^{1 2} (1.School of Biomedical Science and Pharmacy, College of Health Medicine and Wellbeing, University of Newcastle, 2.Centre for Women’s Health Research, Hunter Medical Research Institute, 3.NSW Health Pathology, 4.School of BioSciences, Faculty of Science, The University of Melbourne, 5.School of Environmental and Life Sciences, College of Engineering, Science, and Environment, University of Newcastle, 6.Infertility and Reproduction Program, Hunter Medical Research Institute, 7.Faculty of Science, Medicine, and Health, University of Wollongong)

9:18 〜 9:27

[O1-3]Metabolic Profile Changes between Twins and Singletons Conceived through Assisted Reproductive Technology: A Chinese Prospective Cohort Study

^○Jingmei Hu^{1,2,3,4,5,6,7,8}, Wanbing Feng^{1 2 3 4 5 6 7 8}, Xiaoqian Zhou^{1 2 3 4 5 6 7 8}, Yujia Ren^{1 2 3 4 5 6 7 8} (1.Institute of Women, Children and Reproductive Health,, Shandong University, 2.State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, 3.National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, 4.Shandong Provincial Clinical Research Center for Reproductive Health, Shandong Provincial Clinical Research Center for Reproductive Health, 5. Shandong Technology Innovation Center for Reproductive Health, Shandong Technology Innovation Center for Reproductive Health, 6.Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No.2021RU001, Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No.2021RU001, 7.Key laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, Key laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, 8.Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University)

9:27 〜 9:36

[O1-4]Maternal and perinatal outcomes after modified natural versus artificial/programmed frozen-thawed embryo transfer cycles: a single-institute clinical study of reproductive and perinatal care

^○Maiho Kito, Hisao Ando, Yuka Kawaguchi, Hiroko Minamoto, Noriko Suzuki (Center for Reproductive Medicine and Surgery, Toyohashi Municipal Hospital)

9:36 〜 9:45

[O1-5]Should thyroid peroxidase antibodies (TPO-Ab) be blamed for an elevated pregnancy loss rate mong patients with idiopathic diminished ovarian reserve？A retrospective cohort study

^○Mengxia Ji, Xiaohua Fu (Center for Reproductive Medicine, Department of Reproductive Endocrinology, Zhejiang Provincial People’s Hospital，Hangzhou Medical College)

カテゴリ一覧へ戻る